Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of P...

por Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Publicado 2019

Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia

por Lambert M, Sanchez P, Bergmans P, Gopal S, Mathews M, Wooller A, Pungor K
Publicado 2020

Cognitive deficits in familial schizophrenia

por Aneek Saha, Ekram Goel, Madhura Samudra, Suprakash Chaudhury, Daniel Saldanha
Publicado 2021

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

por Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Publicado 2018

Update on schizophrenia and bipolar disorder: focus on cariprazine

por Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS
Publicado 2016

Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia

por Huang Y, Ma H, Wang Y, Peng M, Zhu G
Publicado 2017

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

por de Filippis R, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, De Fazio P
Publicado 2019

Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders

por Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M
Publicado 2016

Auditory hallucinations across the psychosis spectrum: Evidence of dysconnectivity involving cerebellar and temporal lobe regions

por Melissa Hwang, Youkyung S. Roh, Jessica Talero, Bruce M. Cohen, Justin T. Baker, Roscoe O. Brady, Dost Öngür, Ann K. Shinn
Publicado 2021

Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies

por Xiao B, Wang S, Liu J, Meng T, He Y, Luo X
Publicado 2017

Concurrent conventional & high-definition transcranial direct current stimulation for treatment of schizophrenia with co-morbid obsessive-compulsive disorder: A case report

por Swarna Buddha Nayok, Harsh Pathak, Satish Suhas, Vani H. Thimmashetty, Prakrithi Shivaprakash, Ragibommanahalli M. Madhu Sudhan, Vanteemar S. Sreeraj, Janardhanan C. Narayanaswamy, Ganesan Venkatasubramanian
Publicado 2021

ABCA7 Gene Expression and Genetic Association Study in Schizophrenia

por Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga J, Ohmori T, Ueno S
Publicado 2020

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Ho...

por Mathews M, Gopal S, Singh A, Nuamah I, Pungor K, Tan W, Soares B, Kim E, Savitz AJ
Publicado 2020

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, sub...

por Cuomo I, Kotzalidis GD, de Persis S, Piacentino D, Perrini F, Amici E, De Filippis S
Publicado 2018

Overcoming barriers to effective management of tardive dyskinesia

por Caroff SN
Publicado 2019

Diverse psychiatric presentation associated with child sexual abuse: Case series

por Samiksha Sahu, Suprakash Chaudhury, Vinayak Pathak, Ichpreet Singh, Swaleha Mujawar, Aakanksha Arya, Abha Mishra, Neelu Sharma, Garima Garg
Publicado 2021

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase II...

por Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ
Publicado 2017

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression

por Ni P, Liu M, Wang D, Tian Y, Zhao L, Wei J, Yu X, Qi X, Li X, Yu H, Ni R, Ma X, Deng W, Guo W, Wang Q, Li T
Publicado 2021

Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world cli...

por Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C
Publicado 2019

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate

por Such P, Olivares JM, Arias L, Troels Berg M, Madera J
Publicado 2021